Lin et al. reported that PAI-1 could promote epithelial-mesenchymal transition (EMT) in NSCLC cells by activating the STAT3 signaling pathway, which indicated that PAI-1 could be a biomarker for prognosis prediction and a potential therapeutic target [47]. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.